Cardiovascular

Latest News

Ronesh Sinha, MD | Image credit: Cardiometabolic Health Congress

Dr Ronesh Sinha Talks Digital Health Solutions to Combat Heart Disease Disparities

By Hayden E. Klein
Giuliana Grossi

May 31st 2024

Ronesh Sinha, MD, attributes the rising rates of heart disease to sedentary lifestyles, stress, and health inequities, while advocating for digital health solutions to improve preventive care.

AJMC

Modeling the Economic Value of Cardiometabolic Virtual-First Care Programs

By Madison Noble, MPH
Fang Chen, PhD

May 31st 2024

Older patient with nurse | Image credit: didesign – stock.adobe.com

Statin Therapy Reduces 5-Year CVD Risk in Adults Aged 75 and Older

By Hayden E. Klein

May 27th 2024

Child eating fast food cheeseburger | Image credit: escapejaja – stock.adobe.com

Ultraprocessed Food Consumption Can Increase Children’s Cardiometabolic Risk, Study Says

By Hayden E. Klein

May 17th 2024

Risk Assessments of Drug-Related Problems for Cardiac Surgery Patients

Risk Assessments of Drug-Related Problems for Cardiac Surgery Patients

By Burcu Kelleci Çakır, PhD
Merve Kaşıkcı, MSc

May 10th 2024

Continuing Medical Education

June 1st 2024

Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction

1.0 Credits / Cardiology

Continuing Medical Education

On-Demand Webinar

Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction

1.0 Credits / Cardiology

More News

July 2nd 2015

More Than Half of Cardiovascular Deaths Are Preventable

Laura Joszt, MA

Cardiovascular disease may be the leading cause of death in the United States, but half of those deaths can be prevented, according to researchers from Emory's Rollins School of Public Health.

June 9th 2015

ELIXA Trial Results Find No Cardiac Risk, Benefit for Lixisenatide

Mary K. Caffrey

Results are the first from a cardiovascular safety trial in the GLP-1 agonist class. A commentator at the 75th Scientific Sessions of the American Diabetes Association asked whether the FDA-mandated studies are giving physicians the right information.

June 9th 2015

Sitagliptin Does Not Cause Adverse Cardiovascular Effects, TECOS Trial Finds

Mary K. Caffrey

The long-awaited results, presented Monday at the 75th Scientific Sessions of the American Diabetes Association, are expected to strengthen sitagliptin's position against its competitors in the DPP-4 inhibitor class.

June 7th 2015

5-Year Follow-up After Lifestyle Intervention Examines Cardiovascular Effects of Keeping Weight Off

Mary K. Caffrey

Osama Hamdy, MD, PhD, and other researchers at Joslin Diabetes Center showed that patients with obesity and diabetes who lost at least 7% of their weight the first year stood a better chance of keeping it off.

June 5th 2015

New Study Helps Explain Patient Nonadherence to Cardiovascular Disease Medications

Researchers traced a patient's nonadherence to cardiovascular disease (CVD)-related medications to the number of medications an individual is prescribed as well as at what times these medications need to be taken. While prescribed CVD medications control associated risk factors such as hypertension and hyperlipidemia, more than half of the patients on a prescribed medication plan fail to take their prescriptions as needed.

June 4th 2015

Results of IMPROVE-IT Trial, and Editorial, Affirm Benefits of Lower LDL Cholesterol

Mary K. Caffrey

Authors of an accompanying editorial said the real issue is lowering LDL cholesterol, not necessarily which medication is used.

May 19th 2015

More Young Adults Would Take Statins Under Pediatric Guidelines, Study Finds

Mary K. Caffrey

Until this study, no one had reported on how the discrepancies between adult and pediatric guidelines might affect treatment for young adults.

April 28th 2015

Review Touts Benefits of New Cholesterol Drugs, but Editorial Calls for Cautious Enthusiasm

Mary K. Caffrey

A review of 24 trials covering more than 10,000 patients confirmed earlier findings that PCSK9 inhibitors dramatically reduce cholesterol and risk of heart attacks. But an editorial that appeared alongside the meta-analysis in Annals of Internal Medicine said long-term studies are needed on this new drug class.

April 22nd 2015

Heart Failure Rates Fell From 2000-2010

The incidence rate for heart failure dropped steeply over a decade in a population-based study, and while hospitalization rates remained steady over time, causes shifted from cardiovascular to noncardiovascular.

March 26th 2015

Study Links Fitness Level With Lower Cancer Risk in Men

Mary K. Caffrey

Links between cardiorespiratory fitness and cardiovascular events are well-established. More recently, researchers are turning their attention to the connections between fitness and certain cancers.

March 18th 2015

Mortality, Outcomes, and Healthcare Costs in T2DM Patients at Risk for Cardiovascular Disease

David M. Kern, MS Stephanie DeVore, MSPH Jennifer Kim, PharmD Ozgur Tunceli, PhD Bingcao Wu, MS Boaz Hirshberg, MD

Targeting glucose control and managing cardiovascular (CV) risk factors may prevent future CV events, and have positive downstream impact by reducing costs to healthcare stakeholders.

Cholesterol-Fighting Drug Evolocumab Also Reduces Cardiovascular Events, Study Finds

March 16th 2015

Cholesterol-Fighting Drug Evolocumab Also Reduces Cardiovascular Events, Study Finds

Amgen's cholesterol-fighting PCSK9 inhibitor was shown to reduce the likelihood that patients would suffer cardiovascular events. The question now is whether FDA will grant approval soon and how widely the drug will be used, given speculation about its cost.

February 10th 2015

JAMA Meta-Analysis Confirms Link Between Blood Pressure Treatment, Long-Term Survival for T2DM Patients

Mary K. Caffrey

An editorial accompanying the meta-analysis discussed the challenges physicians face when evaluating individual patient needs against guidelines. In the United States, the movement toward reimbursement based on population health measures has raised questions about whether it makes sense for patients to be given multiple medications to achieve small improvements toward targets. Results must be weighed against increased side affects or large out-of-pocket expenditures.

January 20th 2015

A Look at the Unhealthiness of Sitting, and a Call for More Research on Its Effects

Mary K. Caffrey

The meta-analysis published today and an accompanying editorial should serve as a wake-up call for healthcare organizations about the costs of caring for aging populations that have spent much of their lives behind desks and watching TV.

November 26th 2014

ACO Coalition Looks at Managed Care Tools to Help Employers, Promote Patient Engagement

Mary K. Caffrey

The ACO and Emerging Healthcare Delivery Coalition, an initiative of The American Journal of Managed Care, held its most recent WebEx session this week. Participants discussed new strategies and technologies that both employers and healthcare organizations can use to get patients to take ownership over their own care.

Mentally Ill Die Young From Chronic Disease. Can Psychiatrists Fill a Medical Gap?

September 23rd 2014

Mentally Ill Die Young From Chronic Disease. Can Psychiatrists Fill a Medical Gap?

Patients with serious mental illness die 15 to 20 years earlier than those with similar cardiovascular conditions. According to Joseph P. McEvoy, MD, of the Medical College of Georgia, "There's no mystery here." Cognitive deficits, issues, and lack of access can make it hard for these patients to get primary care, and to stick with the instructions they do receive. To help this group, Dr McEvoy believes psychiatrists can gain competency to treat hypertension, diabetes, obesity and to help these patients quit smoking.

September 5th 2014

Does CAC Testing Alter Downstream Treatment Patterns for Cardiovascular Disease?

Winnie Chia-hsuan Chi, MS Gosia Sylwestrzak, MA John Barron, PharmD Barsam Kasravi, MD, MPH Thomas Power, MD Rita Redberg, MD, MSc

This article provides an assessment of the downstream impact of coronary artery calcium scanning on the subsequent treatment patterns of non—high-risk patients.

September 2nd 2014

USPSTF Ruling, Medicare Policy Change Signal Shift In Recognizing Link Between Chronic Disease, Behavioral Health

Mary K. Caffrey

Two recent policy announcements, one from Medicare and another from the US Preventive Services Task Force, signal a shift toward understanding that America's battle with obesity and diabetes is not only a medical but also a behavioral health problem, and must be treated as such.

August 20th 2014

Contemporary Use of Dual Antiplatelet Therapy for Preventing Cardiovascular Events

Andrew M. Goldsweig, MD Kimberly J. Reid, MS Kensey Gosch, MS Fengming Tang, MS Margaret C. Fang, MD, MPH Thomas M. Maddox, MD, MSc Paul S. Chan, MD, MSc David J. Cohen, MD, MSc Jersey Chen, MD, MPH

Use of dual antiplatelet therapy was modest for patients with existing cardiovascular disease for whom subgroup analysis from a landmark clinical trial suggested benefit in preventing cardiovascular events, and low for patients with multiple risk factors without established cardiovascular disease, for whom increased cardiovascular events were suggested.

July 24th 2014

The Underuse of Carotid Interventions in Veterans With Symptomatic Carotid Stenosis

Salomeh Keyhani Eric Cheng Susan Ofner Linda Williams Dawn Bravata

For patients with symptomatic severe (>70%) carotid stenosis carotid endarterectomy is highly effective at reducing the risk of subsequent stroke; however few eligible Veterans appear to be receiving this procedure.

July 21st 2014

A Novel Pharmaceutical-ACO Collaboration: the Merck/Heritage Provider Network Open Innovation Challenge

Aman Bhandari, PhD Arnaub Chatterjee, MHA, MPA Sara Holoubek, MBA Brian Powers, BA Jonathan Gluck, JD Sachin H. Jain, MD, MBA

Accountable care is forcing providers to develop new capacities and strategies for managing cost and quality trends. Prospectively managing the health of populations requires shifting the focus of care delivery from episodic interventions to continuous population management. As a result, accountable care organizations (ACOs) are dedicating considerable focus to developing the infrastructure and tools needed to help patients manage their chronic conditions. This is a significant departure from traditional care-delivery models and will require provider organizations to develop new partnerships and embrace new methods.

July 21st 2014

Challenge Winner Sees Promise in Daily App Check

Mary K. Caffrey

July 9th 2014

Aetna Sees Promise in New Heart Disease Diagnostic

With spending on diagnostics alone for cardiovascular disease likely to be a major challenge for insurers amid the baby boom wave, Aetna is turning to an emerging option as part of a strategy to avoid invasive tests and treatments.

Gregory L. Fricchione, MD, Discusses Health Reform's Role in Psychiatry and Clinical Medicine

May 30th 2014

Gregory L. Fricchione, MD, Discusses Health Reform's Role in Psychiatry and Clinical Medicine

Gregory L. Fricchione, MD, of Harvard Medical School, says that patients suffering from non-communicable disease face a number of challenges.

May 27th 2014

A Look at Stress, Diabetes, and the Brain: What Are We Learning, and Can Yoga Offer a Solution?

Two articles in Evidence-Based Diabetes Management examine the relationships among stress, diabetes and the brain, and the growing body of research into yoga's positive effects on reducing stress and improving health.

May 22nd 2014

The Persistent Complication of Hypoglycemia in Diabetics

Surabhi Dangi-Garimella, PhD

May 20th 2014

Evidence Builds on Yoga, but No Reimbursement Yet

Mary K. Caffrey

May 15th 2014

CVS Caremark Quits for Good: Our Decision to Stop Selling Tobacco Products

Troyen A. Brennan, MD, MPH, Chief Medical Officer, CVS Caremark

Final Thoughts

April 30th 2014

Transitioning to Value-Based Reimbursement

April 30th 2014

Transitioning to Value-Based Reimbursement

...

14 15 16 17 18 19 20 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions